Severe treatment-resistant autoimmune haemolytic anaemia following ipilimumab in a patient with metastatic melanoma and CLL

Dale Jobson; Christopher J. McCormack; Emma Hiscutt; Constantine Tam

doi:10.1080/10428194.2020.1846735

Severe treatment-resistant autoimmune haemolytic anaemia following ipilimumab in a patient with metastatic melanoma and CLL

Dale Jobson
, Christopher J. McCormack
, Emma Hiscutt
, Constantine Tam

Research output: Contribution to journal › Letter › Other › peer-review

Original language	English
Pages (from-to)	992-994
Number of pages	3
Journal	Leukemia and Lymphoma
Volume	62
Issue number	4
DOIs	https://doi.org/10.1080/10428194.2020.1846735
Publication status	Published - 2021
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1080/10428194.2020.1846735

Cite this

@article{633ac396601047bd85949d9a42a7a88c,

title = "Severe treatment-resistant autoimmune haemolytic anaemia following ipilimumab in a patient with metastatic melanoma and CLL",

author = "Dale Jobson and McCormack, \{Christopher J.\} and Emma Hiscutt and Constantine Tam",

year = "2021",

doi = "10.1080/10428194.2020.1846735",

language = "English",

volume = "62",

pages = "992--994",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Taylor \& Francis",

number = "4",

}

TY - JOUR

T1 - Severe treatment-resistant autoimmune haemolytic anaemia following ipilimumab in a patient with metastatic melanoma and CLL

AU - Jobson, Dale

AU - McCormack, Christopher J.

AU - Hiscutt, Emma

AU - Tam, Constantine

PY - 2021

Y1 - 2021

UR - https://www.scopus.com/pages/publications/85096564007

U2 - 10.1080/10428194.2020.1846735

DO - 10.1080/10428194.2020.1846735

M3 - Letter

C2 - 33222565

AN - SCOPUS:85096564007

SN - 1042-8194

VL - 62

SP - 992

EP - 994

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 4

ER -

Severe treatment-resistant autoimmune haemolytic anaemia following ipilimumab in a patient with metastatic melanoma and CLL

UN SDGs

Access to Document

Other files and links

Cite this